Stevanato Group S.p.A. (NYSE:STVN – Get Free Report) was up 4.9% during trading on Friday after Bank of America raised their price target on the stock from $24.00 to $26.00. Bank of America currently has a buy rating on the stock. Stevanato Group traded as high as €24.90 ($26.21) and last traded at €23.57 ($24.81). Approximately 371,527 shares traded hands during mid-day trading, a decline of 26% from the average daily volume of 499,755 shares. The stock had previously closed at €22.47 ($23.65).
A number of other equities research analysts have also commented on STVN. Morgan Stanley reaffirmed an “equal weight” rating and issued a $23.00 price objective (down from $24.00) on shares of Stevanato Group in a research note on Tuesday, December 3rd. Wolfe Research initiated coverage on Stevanato Group in a research report on Friday. They set an “outperform” rating and a $28.00 target price on the stock. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of €28.60 ($30.11).
Check Out Our Latest Stock Report on STVN
Institutional Inflows and Outflows
Stevanato Group Trading Up 3.7 %
The stock’s fifty day simple moving average is €19.67 and its 200-day simple moving average is €19.67. The company has a debt-to-equity ratio of 0.22, a quick ratio of 1.21 and a current ratio of 1.81.
Stevanato Group (NYSE:STVN – Get Free Report) last posted its earnings results on Tuesday, November 5th. The company reported €0.12 ($0.13) EPS for the quarter, missing the consensus estimate of €0.13 ($0.14) by (€0.01) (($0.01)). The firm had revenue of €277.90 million for the quarter, compared to the consensus estimate of €274.36 million. Stevanato Group had a return on equity of 9.86% and a net margin of 10.47%. Stevanato Group’s quarterly revenue was up 2.4% compared to the same quarter last year. During the same period in the prior year, the business earned $0.16 EPS. On average, analysts expect that Stevanato Group S.p.A. will post 0.5 EPS for the current fiscal year.
About Stevanato Group
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering.
Featured Stories
- Five stocks we like better than Stevanato Group
- The How and Why of Investing in Gold Stocks
- FinWise Bancorp’s CEO Talks Strategy Behind Fintech Success
- Want to Profit on the Downtrend? Downtrends, Explained.
- Broadcom: Turning the Mag 7 Into 8 Trillion-Dollar Tech Giants
- 3 Stocks to Consider Buying in October
- SoundHound AI: Can Its Meteoric Rise Sustain Into 2025?
Receive News & Ratings for Stevanato Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stevanato Group and related companies with MarketBeat.com's FREE daily email newsletter.